Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2025-12-25 @ 12:19 AM
NCT ID:
NCT06750458
Eligibility Criteria:
Inclusion Criteria:
* Males \& females.
* Age: between 18 and 75 years old.
* Pre-operative non-diabetic glioma patients on levetiracetam. • Diagnosis will be confirmed by:
* The initial clinical examination.
* Magnetic resonance imaging of the brain (MRI) with contrast.
Exclusion Criteria:
* Age: \> 75 years old, and \<18 years old.
* Breast feeding female. • Pregnant female.
* eGFR\< 30 mL/minute/1.73 m2.
* Patients with diabetes mellitus.
* Patients with diabetic ketoacidosis.
* Patients with urinary tract infection.
* Dehydrated patients till normalized.
* Lower limb amputation patients.
* SGLT2 inhibitors hypersensitivity.
* Severe hepatic patients (child-plug score class-c).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06750458
Study Brief:
Protocol Section:
NCT06750458